10 February 2013

First Big Pharma Company Announces Support For Clinical Data Transparency Campaign: Who's Next?

It would be something of understatement to say that the spiralling cost of healthcare has become a highly-charged political issue in the US (and elsewhere). But wherever people stand on the funding of medicine, there is an implicit assumption that it works, and is worth even the exorbitant prices that pharmaceutical companies may charge. Sadly, that's often not true. 

On Techdirt.

No comments: